Occluder
Showing 1 - 25 of 140
Lifetech Cera™ PFO Occluder Post-Market Clinical Follow-Up
Not yet recruiting
- Patent Foramen Ovale
- PFO
- The Cera™ PFO Occluder
- (no location specified)
May 30, 2023
Atrial Fibrillation Trial in Shengyang (SeaLA™ left atrial appendage occluder)
Active, not recruiting
- Atrial Fibrillation
- SeaLA™ left atrial appendage occluder
-
Shengyang, ChinaGeneral Hospital of the Northern Theater of the Chinese People's
Jun 24, 2023
Cera™ VSD Occluder Post Market Clinical Follow-up
Not yet recruiting
- Ventricular Septal Defect
- Cera™ VSD occluder implantation
-
Kaohsiung, Taiwan
- +7 more
Jul 3, 2023
Left Atrial Appendage Occlusion Trial in Munich (Left Atrial Appendage Occlusion)
Not yet recruiting
- Left Atrial Appendage Occlusion
- Left Atrial Appendage Occlusion
-
Munich, Bavaria, GermanyKlinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentru
Sep 27, 2023
Atrial Septal Defect Trial in Shanghai (ASD closure with the novel occluder (ReAces), ASD closure with normal occluder)
Recruiting
- Atrial Septal Defect
- ASD closure with the novel occluder (ReAces)
- ASD closure with normal occluder
-
Shanghai, Shanghai, China180 Fenglin Road
May 17, 2022
Nonvalvular Atrial Fibrillation Trial in Beijing, Zhengzhou (E-SeaLA, CardioPulse PFA system)
Recruiting
- Nonvalvular Atrial Fibrillation
- E-SeaLA, CardioPulse PFA system
-
Beijing, Beijing, China
- +1 more
Feb 7, 2023
Patent Ductus Arteriosus Trial in United States (ADO II AS (PDA closure))
Completed
- Patent Ductus Arteriosus
- ADO II AS (PDA closure)
-
Los Angeles, California
- +8 more
Nov 8, 2022
Patent Ductus Arteriosus Trial in Aydin, Adana, Diyarbakir
Recruiting
- Patent Ductus Arteriosus
-
Aydın, Efeler, Turkey
- +2 more
Mar 2, 2022
Stroke, Patent Foramen Ovale Trial in Canada, United States (Investigational PFO Closure Device, Standard of Care PFO Closure
Enrolling by invitation
- Stroke
- Patent Foramen Ovale
- Investigational PFO Closure Device
- Standard of Care PFO Closure Device
-
Stanford, California
- +11 more
Dec 5, 2022
Heart Septal Defect, Heart Septal Defects, Atrial, Heart Defects, Congenital Trial in France, United States (reSept ASD
Recruiting
- Heart Septal Defect
- +6 more
- reSept ASD Occluder
-
Los Angeles, California
- +19 more
Nov 16, 2022
Lifetech MFO Post-Market Clinical Follow-Up Study
Recruiting
- Ventricular Septal Defect
- KONAR-MF™ VSD Occluder
-
Bad Oeynhausen, Germany
- +3 more
Nov 24, 2021
Non-Valvular Atrial Fibrillation Trial in Worldwide (Omega™LAA Occluder implantation)
Recruiting
- Non-Valvular Atrial Fibrillation
- Omega™LAA Occluder implantation
-
København, Blegdamsvej 9, Denmark
- +7 more
Mar 10, 2022
Complications From Left Atrial Appendage Occluder
Completed
- Atrial Fibrillation
- +2 more
- Surgery
-
Kaohsiung, TaiwanDepartment of Surgery, Division of Cardiovascular Surgery
Oct 7, 2021
Trevisio Post-Approval Study
Recruiting
- PFO - Patent Foramen Ovale
- +3 more
- Amplatzer™ Trevisio™ Intravascular Delivery System using Amplatzer PFO Occluder, Amplatzer ASO or Amplatzer Cribriform Occluder
- Amplatzer™ Trevisio™ Intravascular Delivery System using Amplatzer Muscular VSD Occluder or Amplatzer Post-Infarct Muscular VSD Occluder
-
Chambray-lès-Tours, France
- +22 more
Mar 8, 2022
Atrial Septal Defect Trial in Canada (AMPLATZER™ Septal Occluder., Occlutech Figulla Flex II®, GORE® CARDIOFORM ASD Occluder)
Not yet recruiting
- Atrial Septal Defect
- AMPLATZER™ Septal Occluder.
- +2 more
-
Vancouver, British Columbia, Canada
- +3 more
Oct 19, 2022
Talent Converter Post-Approval Study
Terminated
- Abdominal Aortic Aneurysms
- Talent Converter Stent Graft and Talent Occluder with Occluder Delivery System
- (no location specified)
Oct 27, 2021
Muscular Ventricular Septal Defect Trial in Gaziantep (muscular ventricular septal defects)
Recruiting
- Muscular Ventricular Septal Defect
- muscular ventricular septal defects
-
Gaziantep, Şehitkamil, TurkeyGaziantep Unıversıty Hospital
Dec 23, 2022
Amulet™ ADVANCE LAA
Recruiting
- Atrial Fibrillation
- +2 more
- Left atrial appendage occlusion (LAAO)
-
Phoenix, Arizona
- +5 more
Aug 15, 2023
Atrial Septal Defect Trial in United States (GORE® CARDIOFORM ASD Occluder)
Completed
- Atrial Septal Defect
- GORE® CARDIOFORM ASD Occluder
-
Phoenix, Arizona
- +21 more
Nov 10, 2022
The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian
Completed
- Post-Infarction Ventricular Septal Defect
- AMPLATZER™ Post-infarct Muscular VSD Occluder
-
San Francisco, California
- +16 more
Dec 7, 2021
Foramen Ovale, Patent, Septal Defect, Atrial, Septal Defect, Heart Trial in Italy, United States (NobleStitch EL, Amplatzer)
Enrolling by invitation
- Foramen Ovale, Patent
- +2 more
- NobleStitch EL
- Amplatzer
-
Tucson, Arizona
- +3 more
Aug 2, 2022
Patent Foramen Ovale Trial in Nanjing (SnowyTM PFO closure system, Cardi-o-fix PFO occluder)
Not yet recruiting
- Patent Foramen Ovale
- SnowyTM PFO closure system
- Cardi-o-fix PFO occluder
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University
Apr 29, 2022
Atrial Fibrillation, Stroke Trial in United States (CLAAS, WATCHMAN left atrial appendage closure device / Amulet left atrial
Enrolling by invitation
- Atrial Fibrillation
- Stroke
- CLAAS
- WATCHMAN left atrial appendage closure device / Amulet left atrial appendage occluder
-
Birmingham, Alabama
- +5 more
Aug 16, 2022
Stroke in Patients With Non-valvular Atrial Fibrillation
Active, not recruiting
- Atrial Fibrillation
- left atrial appendage occluder implantation
-
Moscow, Russian Federation. National Research Center for Preventive Medicine of the Minist
Dec 24, 2021
Foramen Ovale, Patent, Stroke, Ischemic Trial in Falls Church (NobleStitch EL Suture Mediated Closure System, Amplatzer PFO
Recruiting
- Foramen Ovale, Patent
- Stroke, Ischemic
- NobleStitch EL Suture Mediated Closure System
- Amplatzer PFO Occluder
-
Falls Church, VirginiaInova Cardiovascular Institute
Apr 20, 2021